Search | HMA-EMA Catalogues of real-world data sources and studies

Results(4677)

Clinical Data Warehouse of the Bordeaux University Hospital

France

First published:

01/02/2024

Last updated 12/06/2026

Data source

Human

Other

Record completeness: 94%

Compare Compare

Frequency of HIV diagnoses among people using oral and LA PrEP (223555)

United States

EU PAS number:

EUPAS1000000371

First published:

21/11/2024

Last updated 12/06/2026

Study Ongoing

Belzutifan special drug use results survey in radically unresectable or metastatic renal cell carcinoma: a postauthorization safety study (PASS) (MK-6482-045)

Japan

EU PAS number:

EUPAS1000000880

First published:

20/02/2026

Last updated 12/06/2026

Study Ongoing

Belzutifan special drug use results survey in von Hippel-Lindau (VHL) disease-associated tumors: a post-authorization safety study (PASS) (MK-6482-046)

Japan

EU PAS number:

EUPAS1000000881

First published:

20/02/2026

Last updated 12/06/2026

Study Planned

Ustekinumab and Risk of Small for Gestational Age in Inflammatory Bowel Disease Pregnancies: Data from the DUMBO Registry

Spain

EU PAS number:

EUPAS1000001012

First published:

02/06/2026

Last updated 11/06/2026

Study Finalised

Retrospective Multi-center Study of the Burden of MBL-producing Enterobacterales in Critically Ill Adults in Spain

Spain

EU PAS number:

EUPAS1000000733

First published:

05/01/2026

Last updated 11/06/2026

Study Ongoing

DARWIN EU® - Azathioprine - user characteristics

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000322

First published:

26/09/2024

Last updated 11/06/2026

Study Finalised

Effectiveness of LORlatinib as a Real-World, first-line treatment in ALK-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients in Italy(LOR-ALK).

Italy

EU PAS number:

EUPAS1000000856

First published:

10/06/2026

Last updated 10/06/2026

Study Planned

A Post-Authorisation Safety Study to Evaluate the Safety of Marstacimab Among Patients with Haemophilia A or B using Real-World Data in Haemophilia Registers

United Kingdom

United States

EU PAS number:

EUPAS1000000947

First published:

10/06/2026

Last updated 10/06/2026

Study Planned

Real World Use, Effectiveness and Safety of Romosozumab among Osteoporosis Patients in Guangdong China (20250009)

China

EU PAS number:

EUPAS1000000758

First published:

16/10/2025

Last updated 10/06/2026

Study Ongoing

A multicentre, non-interventional, cohort analysis describing the patients’ experience focusing on safety events among metastatic hormone-sensitive prostate cancer patients treated with Androgen Receptor Pathway Inhibitors (ARPIs) followed through a Telemonitoring tool funded by the French national healthcare insurance complemented with a chart review (ESPERANTO)

France

EU PAS number:

EUPAS1000000759

First published:

07/10/2025

Last updated 10/06/2026

Study Ongoing

TAK-755-4007: A Post-Authorization Safety Study (PASS) to Further Evaluate Real-World Safety in Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated with Adzynma

Austria

France

Germany

Italy

Poland

Spain

Switzerland

United Kingdom

EU PAS number:

EUPAS1000000870

First published:

14/01/2026

Last updated 10/06/2026

Study Ongoing

Evaluating the Effectiveness of Eliquis® Additional Risk Minimization Measures in Kingdom of Saudi Arabia.

Saudi Arabia

EU PAS number:

EUPAS1000000270

First published:

21/05/2025

Last updated 10/06/2026

Study Ongoing

An Observational Study to Describe the Long-term Safety and Effectiveness of Namuscla in the Symptomatic Management of Myotonia in Adult Patients with Non-dystrophic Myotonic Disorders

France

Germany

United Kingdom

EU PAS number:

EUPAS37943

First published:

10/11/2020

Last updated 10/06/2026

Study Ongoing

The Swedish Multiple Sclerosis Registry

Sweden

First published:

09/06/2026

Last updated 09/06/2026

Data source

Human

Disease registry

Record completeness: 90%

Compare Compare

Oslo University Hospital Clinical Data Warehouse

Norway

First published:

30/08/2024

Last updated 09/06/2026

Data source

Human

Hospital discharge records Hospital inpatient records Hospital outpatient visit records Other

Record completeness: 91%

Compare Compare

The European HBV Registry - A joint initiative of TherVacB and DZIF

Germany

Italy

Spain

First published:

01/02/2024

Last updated 09/06/2026

Data source

Human

Disease registry

Record completeness: 87%

Compare Compare

Pregnancy Exposures and Outcomes in Women with Inflammatory Bowel Disease Treated with Risankizumab: A Cohort Study Utilizing Large Electronic Healthcare Databases with Mother-Baby Linkage in the United States

United States

EU PAS number:

EUPAS1000000283

First published:

06/08/2024

Last updated 09/06/2026

Study Ongoing

DARWIN EU® - Characterising the use of JAK inhibitors in Europe: a Drug Utilisation Study Update

Croatia

Denmark

Finland

Germany

Spain

Sweden

EU PAS number:

EUPAS1000000998

First published:

08/05/2026

Last updated 09/06/2026

Study Ongoing

DARWIN EU® - Characteristics of individuals with acute graft vs. host disease with intestinal involvement

France

Germany

Spain

EU PAS number:

EUPAS1000000878

First published:

17/12/2025

Last updated 09/06/2026

Study Ongoing

The European HBV Registry: A joint initiative of TherVacB and DZIF (HBV Registry)

Germany

Italy

Spain

United Kingdom

EU PAS number:

EUPAS42767

First published:

03/09/2021

Last updated 09/06/2026

Study Ongoing

TARGET-EU: Feasibility assessment based on the Data Quality Framework for EU medicines regulation.

Belgium

Denmark

Finland

Greece

Italy

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000791

First published:

31/10/2025

Last updated 08/06/2026

Study Finalised

The Valencia Health System Integrated Database

Spain

First published:

01/02/2024

Last updated 08/06/2026

Data source

Human

Hospital outpatient visit records Other Primary care medical records Registration with healthcare system

Record completeness: 97%

Compare Compare

Pan European Prospective Observational Study of Fremanezumab effectiveness in patients with chronic or episodic migraine in the Real-World: PEARL study

Czechia

Denmark

Finland

Greece

Italy

Norway

Portugal

Spain

Sweden

Switzerland

United Kingdom

EU PAS number:

EUPAS35111

First published:

07/05/2020

Last updated 05/06/2026

Study Finalised

Observational Cohort Study Evaluating Real-World ABRYSVO Vaccine Effectiveness and Impact Against Medically-Attended RSV-related and All-Cause Outcomes Among Infants Born to Individuals Vaccinated During Pregnancy

United States

EU PAS number:

EUPAS1000000295

First published:

22/12/2024

Last updated 05/06/2026

Study Ongoing

OBSERVATIONAL SAFETY AND EFFECTIVENESS STUDY OF PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH TOCILIZUMAB

Germany

United States

EU PAS number:

EUPAS10547

First published:

07/08/2015

Last updated 05/06/2026

Study Finalised

Prospective observational study to assess the long term safety profile of venetoclax in a Swedish cohort of Chronic Lymphocytic Leukaemia (CLL) patients

Sweden

EU PAS number:

EUPAS19010

First published:

12/06/2017

Last updated 05/06/2026

Study Ongoing

Demyelinating Risk with TNF Inhibitors versus Other Targeted DMARDs in Rheumatoid Arthritis: A French Nationwide Claims Study (DEMY-TNF)

France

EU PAS number:

EUPAS1000001021

First published:

05/06/2026

Last updated 05/06/2026

Study Ongoing

A prospective non-interventional post-authorization safety study (PASS) of lenalidomide in previously untreated adult multiple myeloma patients who are not eligible for transplant (“transplant noneligible” [TNE]) (“Revlimid® TNE NDMM PASS”) (CC-5013-MM-034)

Austria

Belgium

Denmark

France

Germany

Ireland

Italy

Netherlands

Norway

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS10153

First published:

12/05/2017

Last updated 04/06/2026

Study Ongoing

Post-marketing Study Assessing the Serious Cardiovascular Events Among Osteoporotic Patients Initiating Romosozumab in Japan Using the Medical Information Database Network (MID-NET) (20190206)

Japan

EU PAS number:

EUPAS1000000308

First published:

23/09/2024

Last updated 04/06/2026

Study Ongoing

Long-term cardiovascular safety and real-world use of eptinezumab - An observational, historical cohort study of patients initiating eptinezumab in routine clinical practice

Denmark

Germany

Italy

United States

EU PAS number:

EUPAS1000000882

First published:

28/01/2026

Last updated 03/06/2026

Study Planned

OXON Epidemiology

Spain

United Kingdom

First published:

06/12/2010

Last updated 03/06/2026

Institution Laboratory/Research/Testing facility Non-Pharmaceutical company ENCePP partner

CSEU La Salle

Spain

First published:

03/06/2026

Last updated 03/06/2026

Institution Educational Institution

A Post-Authorisation Safety Study (PASS) of ABRYSVO (Respiratory Syncytial Virus Stabilised Prefusion Subunit Vaccine) in Pregnant Women and their Offspring in a Real World Setting in Europe and UK (C3671026)

Denmark

France

Netherlands

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000000399

First published:

13/01/2025

Last updated 03/06/2026

Study Ongoing

Evaluation of the effectiveness of Penthrox® (methoxyflurane) educational tools adopted as additional risk minimisation measures: Healthcare professional and Patient Survey (Penthrox-Survey)

United Kingdom

EU PAS number:

EUPAS13034

First published:

05/04/2016

Last updated 03/06/2026

Study Finalised

Myozyme (alglucosidase alfa) Safety Information Packet effectiveness evaluation: a health care professional survey

France

Germany

Italy

Poland

Spain

United Kingdom

EU PAS number:

EUPAS10301

First published:

15/07/2015

Last updated 03/06/2026

Study Finalised

Evaluation of the effectiveness of the belatacept (Nulojix®) Patient Alert Card in patients following renal transplantation in European Economic Area countries.

Austria

France

Germany

Sweden

EU PAS number:

EUPAS10046

First published:

24/06/2015

Last updated 03/06/2026

Study Finalised

Evaluation of the effectiveness of the abatacept (ORENCIA®) intravenous and subcutaneous formulation Patient Alert Cards in patients with rheumatoid arthritis in a sample of European Economic Area countries

France

Germany

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS10122

First published:

30/06/2015

Last updated 03/06/2026

Study Finalised

Post Authorisation Safety Study (PASS) to Evaluate the Risks of Hepatotoxicity and Nephrotoxicity from Administration of Methoxyflurane (Penthrox®) for Pain Relief in Hospital Accident & Emergency Departments in the United Kingdom (Penthrox-PASS)

United Kingdom

EU PAS number:

EUPAS13040

First published:

05/04/2016

Last updated 03/06/2026

Study Finalised

Non-interventional study with Binosto 70 mg effervescent tablets once weekly investigating gastro-intestinal events and medication errors (Gastro-PASS)

Italy

Spain

EU PAS number:

EUPAS10888

First published:

04/09/2015

Last updated 03/06/2026

Study Finalised

Search all content

Results(4677)